LAMP makes Salmonella screening faster—but not independent of sampling design

The FDA’s October update of its LAMP protocol for Salmonella detection places a rapid molecular method in a very specific setting: retail-meat surveillance. The assay amplifies a sequence in the invasion gene invA at a constant temperature; according to the protocol, the system has been adopted by the US NARMS programme as its uniform Salmonella screening method for retail meat. LAMP’s operational advantage is that it does not require the temperature cycles of conventional PCR. The protocol describes use on three instrument platforms and emphasises the method’s tolerance of matrix inhibitors. With overnight enrichment, the documentation reports detection of 1 CFU in 25-gram portions across different food matrices. These are relevant capabilities for high-throughput surveillance, but they do not amount to an instant result taken directly from meat. The guidance itself defines the crucial boundary: the procedure is designed as a screen. Sample preparation, enrichment, controls, signal interpretation and instrument validation remain inseparable parts of the result. Treating LAMP merely as a rapid test without those stages risks trading time for analytical certainty. For plants, laboratories and control programmes, the larger significance lies elsewhere: a uniform method can make signals comparable across sampling sites and campaigns. It creates value only when embedded in a plan that specifies which lot, surface or point in the chain will be investigated after a positive finding. Molecular speed improves response; it does not replace sampling-system design.